BioCardia, Inc. Accounts Payable
BioCardia, Inc. (BCDA) had Accounts Payable of $541.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $541.00K.
- 2026-03-31: Accounts Payable, Current $820.00K.
- 2025-12-31: Accounts Payable, Current $641.00K.
- 2025-09-30: Accounts Payable, Current $1.08M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $541.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $820.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $641.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.08M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.23M 10-Q/A · filed 2025-10-29 | |
| 2025-03-31 | $818.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $385.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $569.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.45M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.03M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $890.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $507.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $686.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $861.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $683.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $887.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $999.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $764.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $507.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $846.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $970.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $850.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $746.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.21M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $1.52M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.11M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $914.00K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $1.11M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $1.63M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.14M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $743.00K 10-K · filed 2020-04-09 | $1.02M 10-K · filed 2019-04-02 |
| 2018-09-30 | $1.10M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $505.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $738.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $902.00K 10-K · filed 2019-04-02 | |
| 2017-09-30 | $447.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $590.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $291.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $525.00K 10-K · filed 2018-03-16 | |
| 2015-12-31 | $542.00K 10-K · filed 2017-03-30 | |
| 2012-12-31 | $0.00 10-K · filed 2013-03-22 | |
| 2011-12-31 | $127.00K 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |